PrEP Biopharm
Menu
About Us
Technology & Pipeline
News & Events
Contact Us
News & Events
Press Releases
On: May 20, 2018
Safety and efficacy of PrEP-001, a novel immunomodulator, for prevention of viral respiratory infection in subjects with asthma
On: May 20, 2018
Safety and nasal cytokine response of PrEP-001, a novel immunomodulatory nasal spray for prophylaxis of respiratory viral infections
on March 19, 2018
Publication: PrEP-001 prophylactic effect against rhinovirus and influenza virus - RESULTS of 2 randomized trials
London, United Kingdom, August 11, 2016
PrEP Biopharm Limited announces addition of Jim Cornelius and Clive Page to its Board of Directors
Nov. 2, 2015
PrEP Biopharm Limited Closes GBP 21 Million Series A Financing